205 related articles for article (PubMed ID: 34907272)
1. Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy.
Rubiś PP; Dziewięcka EM; Banyś P; Urbańczyk-Zawadzka M; Krupiński M; Mielnik M; Łach J; Ząbek A; Wiśniowska-Śmiałek S; Podolec P; Karabinowska A; Holcman K; Garlitski AC
Sci Rep; 2021 Dec; 11(1):24000. PubMed ID: 34907272
[TBL] [Abstract][Full Text] [Related]
2. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
[TBL] [Abstract][Full Text] [Related]
3. A novel cardiac magnetic resonance-based personalized risk stratification model in dilated cardiomyopathy: a prospective study.
Zhou D; Zhu L; Wu W; Zhuang B; He J; Xu J; Yang W; Wang Y; Li S; Sun X; Sharma P; Liu G; Sirajuddin A; Arai A; Zhao S; Lu M
Eur Radiol; 2024 Jun; 34(6):4053-4064. PubMed ID: 37950081
[TBL] [Abstract][Full Text] [Related]
4. T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study.
Li S; Zhou D; Sirajuddin A; He J; Xu J; Zhuang B; Huang J; Yin G; Fan X; Wu W; Sun X; Zhao S; Arai AE; Lu M
JACC Cardiovasc Imaging; 2022 Apr; 15(4):578-590. PubMed ID: 34538631
[TBL] [Abstract][Full Text] [Related]
5. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
[TBL] [Abstract][Full Text] [Related]
6. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
7. Temporal progression of replacement and interstitial fibrosis in optimally managed dilated cardiomyopathy patients: A prospective study.
Rubiś P; Banyś P; Krupiński M; Mielnik M; Wiśniowska-Śmiałek S; Dziewięcka E; Urbańczyk-Zawadzka M
Int J Cardiol; 2024 Jul; 407():131988. PubMed ID: 38547964
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy.
Cadour F; Quemeneur M; Biere L; Donal E; Bentatou Z; Eicher JC; Roubille F; Lalande A; Giorgi R; Rapacchi S; Cortaredona S; Tradi F; Bartoli A; Willoteaux S; Delahaye F; Biene SM; Mangin L; Ferrier N; Dacher JN; Bauer F; Leurent G; Lentz PA; Kovacsik H; Croisille P; Thuny F; Bernard M; Guye M; Furber A; Habib G; Jacquier A
J Cardiovasc Magn Reson; 2023 Feb; 25(1):7. PubMed ID: 36747201
[TBL] [Abstract][Full Text] [Related]
9. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
[TBL] [Abstract][Full Text] [Related]
10. Cardiac MRI for clinical dilated cardiomyopathy: Improved diagnostic power via combined T1, T2, and ECV.
Jia SQ; Lv SY; Jin YH; Zhao Y; Tian LP; Chang MM; Yan CL; Qi XL
Radiography (Lond); 2024 May; 30(3):926-931. PubMed ID: 38657385
[TBL] [Abstract][Full Text] [Related]
11. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
[TBL] [Abstract][Full Text] [Related]
12. Lack of Relationship between Fibrosis-Related Biomarkers and Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis in Dilated Cardiomyopathy.
Rubiś P; Dziewięcka E; Szymańska M; Banyś R; Urbańczyk-Zawadzka M; Krupiński M; Mielnik M; Wiśniowska-Śmiałek S; Karabinowska A; Podolec P; Winiarczyk M; Gliniak M; Kaciczak M; Robak J; Karapetyan A; Wypasek E
Cells; 2021 May; 10(6):. PubMed ID: 34071085
[TBL] [Abstract][Full Text] [Related]
13. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.
Vita T; Gräni C; Abbasi SA; Neilan TG; Rowin E; Kaneko K; Coelho-Filho O; Watanabe E; Mongeon FP; Farhad H; Rassi CH; Choi YL; Cheng K; Givertz MM; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Kwong RY
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1659-1669. PubMed ID: 30448130
[TBL] [Abstract][Full Text] [Related]
14. Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long-term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy Delivery) Registry.
Pedretti S; Vargiu S; Baroni M; Dellegrottaglie S; Lanzarin B; Roghi A; Milazzo A; Quattrocchi G; Lunati M; Pedrotti P
Clin Cardiol; 2018 Apr; 41(4):494-501. PubMed ID: 29663442
[TBL] [Abstract][Full Text] [Related]
15. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
[TBL] [Abstract][Full Text] [Related]
16. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.
Latus H; Gummel K; Klingel K; Moysich A; Khalil M; Mazhari N; Bauer J; Kandolf R; Schranz D; Apitz C
J Cardiovasc Magn Reson; 2015 May; 17(1):34. PubMed ID: 25976093
[TBL] [Abstract][Full Text] [Related]
17. Extracellular volume fraction improves risk-stratification for ventricular arrhythmias and sudden death in non-ischaemic cardiomyopathy.
Di Marco A; Brown PF; Bradley J; Nucifora G; Anguera I; Miller CA; Schmitt M
Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):512-521. PubMed ID: 35877070
[TBL] [Abstract][Full Text] [Related]
18. Fat deposition in dilated cardiomyopathy assessed by CMR.
Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
[TBL] [Abstract][Full Text] [Related]
19. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
[TBL] [Abstract][Full Text] [Related]
20. Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation.
Cui Y; Cao Y; Song J; Dong N; Kong X; Wang J; Yuan Y; Zhu X; Yan X; Greiser A; Shi H; Han P
J Cardiovasc Magn Reson; 2018 Apr; 20(1):25. PubMed ID: 29681243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
